Rotavirus-neutralizing antibodies inhibit virus binding to integrins α2β1 and α4β1

Archives of Virology

Volumn 152, Issue 6, 2007, Pages 1087-1101

  Fleming, F E ^a   Graham, K L ^a   Taniguchi, K ^b   Takada, Y ^c   Coulson, B S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; MONOCLONAL ANTIBODY; NS35 PROTEIN, ROTAVIRUS; NSP1 PROTEIN, ROTAVIRUS; RNA BINDING PROTEIN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 2; VERY LATE ACTIVATION ANTIGEN 4; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS PROTEIN; VP7 PROTEIN, ROTAVIRUS;

ARTICLE; CELL LINE; CELL STRAIN K 562; CHILD; GASTROENTERITIS; HUMAN; IMMUNOLOGY; IN VITRO STUDY; METABOLISM; PATHOGENICITY; ROTAVIRUS; SERODIAGNOSIS; VIROLOGY; VIRUS INFECTION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; CELL LINE; CHILD; GASTROENTERITIS; HUMANS; INTEGRIN ALPHA2BETA1; INTEGRIN ALPHA4BETA1; K562 CELLS; NEUTRALIZATION TESTS; RNA-BINDING PROTEINS; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIRAL NONSTRUCTURAL PROTEINS;

HUMAN ROTAVIRUS A; MIRIDAE; ROTAVIRUS;

EID: 34249071415     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-007-0937-x     Document Type: Article

References (79)

1. Bass DM, Mackow ER, Greenberg HB (1991) Identification and partial characterization of a rhesus rotavirus binding glycoprotein on murine enterocytes. Virology 183: 602-610
2. Beards GM, Desselberger U (1989) Determination of rotavirus serotype-specific antibodies in sera by competitive enhanced enzyme immunoassay. J Virol Methods 24: 103-110
3. Ciarlet M, Estes MK (1999) Human and most animal rotavirus strains do not require the presence of sialic acid on the cell surface for efficient infectivity. J Gen Virol 80: 943-948
4. Ciarlet M, Crawford SE, Cheng E, Blutt SE, Rice DA, Bergelson JM, Estes MK (2002) VLA-2 (a2b1) integrin promotes rotavirus entry into cells but is not necessary for rotavirus attachment. J Virol 76: 1109-1123
5. Ciarlet M, Ludert JE, Iturriza-Gomara M, Liprandi F, Gray JJ, Desselberger U, Estes MK (2002) Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol 76: 4087-4095
6. Coulson BS, Fowler KJ, Bishop RF, Cotton RG (1985) Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates. J Virol 54: 14-20
7. Coulson BS, Tursi JM, McAdam WJ, Bishop RF (1986) Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3. Virology 154: 302-312
8. Coulson BS (1987) Variation in neutralization epitopes of human rotaviruses in relation to genomic RNA polymorphism. Virology 159: 209-216
9. Coulson BS, Unicomb LE, Pitson GA, Bishop RF (1987) Simple and specific enzyme immunoassay using monoclonal antibodies for serotyping human rotaviruses. J Clin Microbiol 25: 509-515
10. Coulson BS, Grimwood K, Bishop RF, Barnes GL (1989) Evaluation of end-point titration, single dilution and capture enzyme immunoassays for measurement of antirotaviral IgA and IgM in infantile secretions and serum. J Virol Methods 26: 53-65
11. Coulson BS, Grimwood K, Masendycz PJ, Lund JS, Mermelstein N, Bishop RF, Barnes GL (1990) Comparison of rotavirus immunoglobulin A coproconversion with other indices of rotavirus infection in a longitudinal study in childhood. J Clin Microbiol 28: 1367-1374
12. Coulson BS, Masendycz PJ (1990) Measurement of rotavirus-neutralizing coproantibody in children by fluorescent focus reduction assay. J Clin Microbiol 28: 1652-1654
13. Coulson BS, Kirkwood C (1991) Relation of VP7 amino acid sequence to monoclonal antibody neutralization of rotavirus and rotavirus monotype. J Virol 65: 5968-5974
14. Coulson BS, Grimwood K, Hudson IL, Barnes GL, Bishop RF (1992) Role of coproantibody in clinical protection of children during reinfection with rotavirus. J Clin Microbiol 30: 1678-1684
15. Coulson BS, Londrigan SL, Lee DJ (1997) Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells. Proc Natl Acad Sci USA 94: 5389-5394
16. Coulson BS (1998) Longitudinal studies of neutralizing antibody responses to rotavirus in stools and sera of children following severe rotavirus gastroenteritis. Clin Diagn Lab Immunol 5: 897-901
17. Crawford SE, Labbe M, Cohen J, Burroughs MH, Zhou YJ, Estes MK (1994) Characterization of virus-like particles produced by the expression of rotavirus capsid proteins in insect cells. J Virol 68: 5945-5952
18. Delorme C, Brussow H, Sidoti J, Roche N, Karlsson KA, Neeser JR, Teneberg S (2001) Glycosphingolipid binding specificities of rotavirus: identification of a sialic acid-binding epitope. J Virol 75: 2276-2287
19. Denisova E, Dowling W, LaMonica R, Shaw R, Scarlata S, Ruggeri F, Mackow ER (1999) Rotavirus capsid protein VP5* permeabilizes membranes. J Virol 73: 3147-3153
20. Dormitzer PR, Sun ZY, Wagner G, Harrison SC (2002) The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site. EMBO J 21: 885-897
21. Dormitzer PR, Nason EB, Prasad BV, Harrison SC (2004) Structural rearrangements in the membrane penetration protein of a non-enveloped virus. Nature 430: 1053-1058
22. Dowling W, Denisova E, LaMonica R, Mackow ER (2000) Selective membrane permeabilization by the rotavirus VP5* protein is abrogated by mutations in an internal hydrophobic domain. J Virol 74: 6368-6376
23. Dyall-Smith ML, Lazdins I, Tregear GW, Holmes IH (1986) Location of the major antigenic sites involved in rotavirus serotype-specific neutralization. Proc Natl Acad Sci USA 83: 3465-3468
24. Espejo RT, Lopez S, Arias C (1981) Structural polypeptides of simian rotavirus SA11 and the effect of trypsin. J Virol 37: 156-160
25. Estes MK, Graham DY, Mason BB (1981) Proteolytic enhancement of rotavirus infectivity: molecular mechanisms. J Virol 39: 879-888
26. Fiore L, Greenberg HB, Mackow ER (1991) The VP8 fragment of VP4 is the rhesus rotavirus hemagglutinin. Virology 181: 553-563
27. Flores J, Perez-Schael I, Gonzalez M, Garcia D, Perez M, Daoud N, Cunto W, Chanock RM, Kapikian AZ (1987) Protection against severe rotavirus diarrhoea by rhesus rotavirus vaccine in Venezuelan infants. Lancet 1: 882-884
28. Franco MA, Angel J, Greenberg HB (2006) Immunity and correlates of protection for rotavirus vaccines. Vaccine 24: 2718-2731
29. Fukudome K, Yoshie O, Konno T (1989) Comparison of human, simian, and bovine rotaviruses for requirement of sialic acid in hemagglutination and cell adsorption. Virology 172: 196-205
30. Ghose LH, Schnagl RD, Holmes IH (1978) Comparison of an enzyme-linked immunosorbent assay for quantitation of rotavirus antibodies with complement fixation in an epidemiological survey. J Clin Microbiol 8: 268-276
31. Gilbert JM, Greenberg HB (1998) Cleavage of rhesus rotavirus VP4 after arginine 247 is essential for rotavirus-like particle-induced fusion from without. J Virol 72: 5323-5327
32. Graham KL, Halasz P, Tan Y, Hewish MJ, Takada Y, Mackow ER, Robinson MK, Coulson BS (2003) Integrin-using rotaviruses bind α2β1 integrin α2 I domain via VP4 DGE sequence and recognize αXβ2 and αVβ3 by using VP7 during cell entry. J Virol 77: 9969-9978
33. Graham KL, Zeng W, Takada Y, Jackson DC, Coulson BS (2004) Effects on rotavirus cell binding and infection of monomeric and polymeric peptides containing α2β1 and αxβ2 integrin ligand sequences. J Virol 78: 11786-11797
34. Graham KL, Fleming FE, Halasz P, Hewish MJ, Nagesha HS, Holmes IH, Takada Y, Coulson BS (2005) Rotaviruses interact with α4β7 and α4β1 integrins by binding the same integrin domains as natural ligands. J Gen Virol 86: 3397-3408
35. Graham KL, Takada Y, Coulson BS (2006) Rotavirus spike protein VP5* binds α2β1 integrin on the cell surface and competes with virus for cell binding and infectivity. J Gen Virol 87: 1275-1283
36. Green KY, Taniguchi K, Mackow ER, Kapikian AZ (1990) Homotypic and heterotypic epitope-specific antibody responses in adult and infant rotavirus vaccines: implications for vaccine development. J Infect Dis 161: 667-679
37. Green KY, Kapikian AZ (1992) Identification of VP7 epitopes associated with protection against human rotavirus illness or shedding in volunteers. J Virol 66: 548-553
38. Greenberg HB, Valdesuso J, van Wyke K, Midthun K, Walsh M, McAuliffe V, Wyatt RG, Kalica AR, Flores J, Hoshino Y (1983) Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol 47: 267-275
39. Guerrero CA, Mendez E, Zarate S, Isa P, Lopez S, Arias CF (2000) Integrin avb3 mediates rotavirus cell entry. Proc Natl Acad Sci USA 97: 14644-14649
40. Guo CT, Nakagomi O, Mochizuki M, Ishida H, Kiso M, Ohta Y, Suzuki T, Miyamoto D, Hidari KI, Suzuki Y (1999) Ganglioside GM(1a) on the cell surface is involved in the infection by human rotavirus KUN and MO strains. J Biochem (Tokyo) 126: 683-688
41. Haselhorst T, Blanchard H, Frank M, Kraschnefski MJ, Kiefel MJ, Szyczew AJ, Dyason JC, Fleming F, Holloway G, Coulson BS, von Itzstein M (2007) STD NMR spectroscopy and molecular modeling investigation of the binding of N-acetylneuraminic acid derivatives to rhesus rotavirus VP8* core. Glycobiology 17: 68-81
42. Hewish MJ, Takada Y, Coulson BS (2000) Integrins α2β1 and α4β1 can mediate SA11 rotavirus attachment and entry into cells. J Virol 74: 228-236
43. Jolly CL, Beisner BM, Holmes IH (2000) Rotavirus infection of MA104 cells is inhibited by Ricinus lectin and separately expressed single binding domains. Virology 275: 89-97
44. Jolly CL, Beisner BM, Ozser E, Holmes IH (2001) Nonlytic extraction and characterisation of receptors for multiple strains of rotavirus. Arch Virol 146: 1307-1323
45. Kapikian AZ, Hoshino Y, Chanock RM (2001) Rotaviruses. In: Knipe DM, Howley PM (eds) Fields Virology, vol 2. Lippincott, Williams and Wilkins, Philadelphia, pp 1787-1833
46. Kirkwood C, Masendycz PJ, Coulson BS (1993) Characteristics and location of cross-reactive and serotype-specific neutralization sites on VP7 of human G type 9 rotaviruses. Virology 196: 79-88
47. Kirkwood CD, Bishop RF, Coulson BS (1996) Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites. Arch Virol 141: 587-600
48. Kirkwood CD, Bishop RF, Coulson BS (1998) Attachment and growth of human rotaviruses RV-3 and S12/85 in Caco-2 cells depend on VP4. J Virol 72: 9348-9352
49. Klasse PJ, Sattentau QJ (2002) Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J Gen Virol 83: 2091-2108
50. Lazdins I, Coulson BS, Kirkwood C, Dyall-Smith M, Masendycz PJ, Sonza S, Holmes IH (1995) Rotavirus antigenicity is affected by the genetic context and glycosylation of VP7. Virology 209: 80-89
51. Londrigan SL, Hewish MJ, Thomson MJ, Sanders GM, Mustafa H, Coulson BS (2000) Growth of rotaviruses in continuous human and monkey cell lines that vary in their expression of integrins. J Gen Virol 81: 2203-2213
52. Londrigan SL, Graham KL, Takada Y, Halasz P, Coulson BS (2003) Monkey rotavirus binding to α2β1 integrin requires the β2 I domain and is facilitated by the homologous β1 subunit. J Virol 77: 9486-9501
53. Ludert JE, Feng N, Yu JH, Broome RL, Hoshino Y, Greenberg HB (1996) Genetic mapping indicates that VP4 is the rotavirus cell attachment protein in vitro and in vivo. J Virol 70: 487-493
54. Ludert JE, Ruiz MC, Hidalgo C, Liprandi F (2002) Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation. J Virol 76: 6643-6651
55. Mackow ER, Shaw RD, Matsui SM, Vo PT, Dang MN, Greenberg HB (1988) The rhesus rotavirus gene encoding protein VP3: location of amino acids involved in homologous and heterologous rotavirus neutralization and identification of a putative fusion region. Proc Natl Acad Sci USA 85: 645-649
56. Mackow ER, Yamanaka MY, Dang MN, Greenberg HB (1990) DNA amplification-restricted transcription-translation: rapid analysis of rhesus rotavirus neutralization sites. Proc Natl Acad Sci USA 87: 518-522
57. Matson DO, O'Ryan ML, Pickering LK, Chiba S, Nakata S, Raj P, Estes MK (1992) Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays. J Clin Microbiol 30: 1056-1061
58. Matson DO, O'Ryan ML, Pickering LK, Estes MK (1994) Assessment of epitope-blocking assays for measuring antibody to rotavirus. J Virol Methods 48: 293-300
59. McLean B, Sonza S, Holmes IH (1980) Measurement of immunoglobulin A, G, and M class rotavirus antibodies in serum and mucosal secretions. J Clin Microbiol 12: 314-319
60. Menchaca G, Padilla-Noriega L, Mendez-Toss M, Contreras JF, Puerto FI, Guiscafre H, Mota F, Herrera I, Cedillo R, Munoz O, Ward R, Hoshino Y, Lopez S, Arias CF (1998) Serotype specificity of the neutralizing-antibody response induced by the individual surface proteins of rotavirus in natural infections of young children. Clin Diagn Lab Immunol 5: 328-334
61. Monnier N, Higo-Moriguchi K, Sun ZY, Prasad BV, Taniguchi K, Dormitzer PR (2006) High-resolution molecular and antigen structure of the VP8* core of a sialic acid-independent human rotavirus strain. J Virol 80: 1513-1523
62. Padilla-Noriega L, Dunn SJ, Lopez S, Greenberg HB, Arias CF (1995) Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3. Virology 206: 148-154
63. Prasad BV, Burns JW, Marietta E, Estes MK, Chiu W (1990) Localization of VP4 neutralization sites in rotavirus by three-dimensional cryo-electron microscopy. Nature 343: 476-479
64. Rolsma MD, Kuhlenschmidt TB, Gelberg HB, Kuhlenschmidt MS (1998) Structure and function of a ganglioside receptor for porcine rotavirus. J Virol 72: 9079-9091
65. Ruggeri FM, Greenberg HB (1991) Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol 65: 2211-2219
66. Shaw RD, Vo PT, Offit PA, Coulson BS, Greenberg HB (1986) Antigenic mapping of the surface proteins of rhesus rotavirus. Virology 155: 434-451
67. Shaw RD, Fong KJ, Losonsky GA, Levine MM, Maldonado Y, Yolken R, Flores J, Kapikian AZ, Vo PT, Greenberg HB (1987) Epitope-specific immune responses to rotavirus vaccination. Gastroenterology 93: 941-950
68. Sonza S, Breschkin AM, Holmes IH (1984) The major surface glycoprotein of simian rotavirus (SA11) contains distinct epitopes. Virology 134: 318-327
69. Taniguchi K, Maloy WL, Nishikawa K, Green KY, Hoshino Y, Urasawa S, Kapikian AZ, Chanock RM, Gorziglia M (1988) Identification of cross-reactive and serotype 2-specific neutralization epitopes on VP3 of human rotavirus. J Virol 62: 2421-2426
70. Taniguchi K, Urasawa T, Kobayashi N, Ahmed MU, Adachi N, Chiba S, Urasawa S (1991) Antibody response to serotype-specific and cross-reactive neutralization epitopes on VP4 and VP7 after rotavirus infection or vaccination. J Clin Microbiol 29: 483-487
71. Tihova M, Dryden KA, Bellamy AR, Greenberg HB, Yeager M (2001) Localization of membrane permeabilization and receptor binding sites on the VP4 hemagglutinin of rotavirus: implications for cell entry. J Mol Biol 314: 985-992
72. Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, Shinefield HR, Christie CD, Ylitalo S, Itzler RF, Coia ML, Onorato MT, Adeyi BA, Marshall GS, Gothefors L, Campens D, Karvonen A, Watt JP, O'Brien KL, DiNubile MJ, Clark HF, Boslego JW, Offit PA, Heaton PM (2006) Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 354: 23-33
73. Ward RL (2003) Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol 16: 17-24
74. Warner S, Hartley CA, Stevenson RA, Ficorilli N, Varrasso A, Studdert MJ, Crabb BS (2001) Evidence that Equine rhinitis A virus VP1 is a target of neutralizing antibodies and participates directly in receptor binding. J Virol 75: 9274-9281
75. Yeager M, Dryden KA, Olson NH, Greenberg HB, Baker TS (1990) Three-dimensional structure of rhesus rotavirus by cryoelectron microscopy and image reconstruction. J Cell Biol 110: 2133-2144
76. Zarate S, Espinosa R, Romero P, Guerrero CA, Arias CF, Lopez S (2000) Integrin a2b1 mediates the cell attachment of the rotavirus neuraminidase- resistant variant nar3. Virology 278: 50-54
77. Zarate S, Espinosa R, Romero P, Mendez E, Arias CF, Lopez S (2000) The VP5 domain of VP4 can mediate attachment of rotaviruses to cells. J Virol 74: 593-599
78. Zarate S, Cuadras MA, Espinosa R, Romero P, Juarez KO, Camacho-Nuez M, Arias CF, Lopez S (2003) Interaction of rotaviruses with Hsc70 during cell entry is mediated by VP5. J Virol 77: 7254-7260
79. Zarate S, Romero P, Espinosa R, Arias CF, Lopez S (2004) VP7 mediates the interaction of rotaviruses with integrin avb3 through a novel integrin-binding site. J Virol 78: 10839-10847